Home / Epirubicin / Switzerland
CH ATC L01DB03 · updated 2 Nov 2026
Epirubicin shortage in Switzerland
Is there an Epirubicin shortage in Switzerland?
Yes. As of 2 Nov 2026, 5 Epirubicin products are reported short in Switzerland, the first since 30 Jan 2025. The company estimate for the return is 6 Nov 2026 (latest 31 Dec 2026). Main reason: not stated.
Also short in France, Italy, Spain, Austria, Belgium, Czechia. All countries.
Affected products in Switzerland
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CH | FARMORUBICIN RD Trockensub 10 mg c Solv Amp | Pfizer AG | 30 Jan 2025 | 31 Dec 2026 | Not stated |
| CH | EPIRUBICIN Teva liquid 200 mg/100ml Durchstf | Teva Pharma AG | 11 Mar 2026 | 6 Nov 2026 | Not stated |
| CH | EPIRUBICIN Teva liquid 100 mg/50ml Durchstf | Teva Pharma AG | 13 Apr 2026 | 6 Nov 2026 | Not stated |
| CH | FARMORUBICIN RD Trockensub 50 mg Durchstf | Pfizer AG | 18 May 2026 | not given | Not stated |
| CH | EPIRUBICIN Teva liquid 50 mg/25ml Durchstf | Teva Pharma AG | 6 Jul 2026 | 6 Nov 2026 | Not stated |
Source
FONES (Federal Office for National Economic Supply), reporting office for vital medicines. Official list. Vital human medicines only (the federal list of reportable active substances); one row per pack (GTIN).